Every year, the British Association of Urological Surgeons host their Annual Scientific Meeting, and this year the prestigious event returned to the beautiful historic city of Liverpool. Urologists and healthcare practitioners and key opinion leaders are invited to come together to discuss clinical topics and issues that support public health and wellbeing in the field of Urology. These range from Academic Urology and Genito-Urethral Surgery, to Endo-urology and Skills Courses. Those of you among the delegates might have spotted the Arquer Diagnostics team among this years exhibitors, in support of our UK partner, Alpha Laboratories.
Innovative and Significant Breakthroughs
It was a pleasure and an honour to be a part of such an important event across the three days in Liverpool, even more significant for us as this year marks 70 years of the NHS. While incredible, revolutionary strides in healthcare have been made across the last seven decades, there are still many challenges and obstacles to overcome in order to strive towards the best possible treatment and care for our patients. It’s meetings like BAUS which help make innovation and significant breakthroughs possible, and our team at Arquer are proud to be a part of that. To be among such a high quality of inspiring, diverse exhibitors and their products and services is very exciting indeed.
We developed ADXBLADDER in response to a clear clinical demand for a non-invasive alternative to traditional bladder cancer diagnostic methods which was both accurate and reliable. In addition, with an NHS under financial strain – our aim was to also create a more cost-effective solution for cancer testing. It was fantastic to talk first-hand with delegates about our groundbreaking MCM5 technology and introduce them to ADXBLADDER and how it could help revolutionise their diagnose of bladder cancer patients.
The event was truly a success for both the Alpha Labs and the Arquer Diagnostics teams, and we hope to continue to innovate within healthcare, applying our technology to more diagnostic needs and return to BAUS in the future.